Endoron Staples Down $10M To ‘Revolutionize’ Abdominal Aortic Aneurysm Repair
Executive Summary
Endoron Medical won $10m in series A funding from European venture capital firm Sofinnova Partners and the European Innovation Council Fund. The capital will propel Aortoseal – Endoron's endograft stapling solution for abdominal aortic aneurysm – through clinical validation in its US Food and Drug Administration early feasibility study.